
Airway hyperresponsiveness (AHR) is commonly assessed by a methacholine challenge test (MCT), during which a provocative concentration is causing a 20% reduction in forced expiratory volume in 1 second (FEV1) (PC20) < 8 mg/ml is considered a positive response. However, a fall in specific airway conductance (saw) may also have clinical significance. Therefore, this study aimed to assess whether AHR determined by a provocative concentration causing a 40% reduction in sGaw (PC40) < 8 mg/ml corresponds to a clinical diagnosis of asthma. The outcomes demonstrated that the changes in sGaw during MCT indicate clinically significant AHR supporting a clinical diagnosis of asthma among patients being evaluated for asthma.
Like
Save
Share